Indolent B Cell Lymphoma - 25 Studies Found

Completed : Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma
:
  • B-cell Chronic Lymphocytic Leukemia
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-assoc
    : 2008-02-21
    :
    • Biological: therapeutic autologous lymphocytes

Withdrawn : Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma
: Lymphoma
: 1999-12-10
:
  • Biological: recombinant interferon alfa
  • Bi
Withdrawn : Interventional Study on Pentostatin, Cyclophosphamide and Rituximab in Indolent B-Cell Non-Hodgkin-Lymphoma (B-NHL)
:
  • Immunocytoma/Morbus Waldenström
  • B-Cell Non-Hodgkin's Lymphoma
  • T-cell Lymphoma
  • Aggressive B-cell Lymphoma
  • Non-Hodgkin's L
    : 2016-07-25
    :
    • Drug: Decitabine 2-4 capsules

Not yet recruiting : Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL
:
  • Multiple Myeloma
  • Non-Hodgkin Lymphoma
  • Diffuse Large B Cell
    : 2017-01-11
    : Biological: Nicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer Cells Other
<<< Previous